Decentralized trials provide promise for lowering barriers in participation, but industry must continue to be proactive in patient centricity.
Teonna Woolford
Advertisement
CEO, Sickle Cell Reproductive Health Education Directive
Articles by Teonna Woolford
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
2
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
3
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
4
Labels That Withstand Liquid Nitrogen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
